Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the high neg...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Bertoli, Gloria, Cava, Claudia, Corsi, Fabio, Piccotti, Francesca, Martelli, Cristina, Ottobrini, Luisa, Vaira, Valentina, Castiglioni, Isabella
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7985188/
https://ncbi.nlm.nih.gov/pubmed/33753785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85746-w
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki